NewslettersCell Therapy NewsCD3 Aptamers Promote Expansion and Persistence of Tumor-Reactive T Cells for Adoptive T Cell Therapy in CancerBy lbeveridge - April 29, 2024023To identify CD3-specific T cell agonists, several RNA aptamers were selected against CD3 using SELEX combined with high-throughput sequencing.[Molecular Therapy – Nucleic Acids]Abstract